These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31960728)

  • 1. Novel Antiplatelet Agents in Cardiovascular Disease.
    Tscharre M; Michelson AD; Gremmel T
    J Cardiovasc Pharmacol Ther; 2020 May; 25(3):191-200. PubMed ID: 31960728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet drugs: which targets for which treatments?
    Gachet C
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S313-22. PubMed ID: 26149041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-platelet agents: focus on thrombin receptor antagonists.
    de Souza Brito F; Tricoci P
    J Cardiovasc Transl Res; 2013 Jun; 6(3):415-24. PubMed ID: 23435863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel Antiplatelet Agents: The Current State and What Is Coming Down the Pike.
    Franchi F; Rollini F; Park Y; Angiolillo DJ
    Prog Cardiovasc Dis; 2015; 58(3):267-77. PubMed ID: 26277706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.
    Vallés J; Moscardo A; Madrid I; Santos MT
    Curr Vasc Pharmacol; 2013 Jul; 11(4):431-47. PubMed ID: 23905638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future antiplatelet therapies: emphasis on preserving haemostasis.
    McFadyen JD; Schaff M; Peter K
    Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic.
    Xiang Q; Pang X; Liu Z; Yang G; Tao W; Pei Q; Cui Y
    Pharmacol Ther; 2019 Nov; 203():107393. PubMed ID: 31356909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.
    Cho JR; Rollini F; Franchi F; Ferrante E; Angiolillo DJ
    Vasc Health Risk Manag; 2014; 10():177-88. PubMed ID: 24729713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiplatelet therapy in acute coronary syndromes: what is new in the pipeline?
    Müller KA; Geisler T
    Curr Vasc Pharmacol; 2012 Sep; 10(5):606-18. PubMed ID: 22724478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined antiplatelet therapy: still a sweeping combination in cardiology.
    Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Clopidogrel in 2020: A Reappraisal.
    Patti G; Micieli G; Cimminiello C; Bolognese L
    Cardiovasc Ther; 2020; 2020():8703627. PubMed ID: 32284734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
    Alexopoulos D; Katogiannis K; Sfantou D; Lekakis J
    Platelets; 2018 May; 29(3):228-237. PubMed ID: 29022423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation.
    Stylos E; Chatziathanasiadou MV; Tsiailanis A; Kellici TF; Tsoumani M; Kostagianni AD; Deligianni M; Tselepis AD; Tzakos AG
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2609-2618. PubMed ID: 28844979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of clopidogrel.
    Sarafoff N; Byrne RA; Sibbing D
    Curr Pharm Des; 2012; 18(33):5224-39. PubMed ID: 22724411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Antiplatelet Therapy in Acute Coronary Syndrome.
    Dash D
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):40-9. PubMed ID: 26245659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases.
    Jourdi G; Lordkipanidzé M; Philippe A; Bachelot-Loza C; Gaussem P
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring oral antiplatelet therapy: is it justified?
    Ang L; Mahmud E
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of the antiplatelet effect of aspirin.
    Würtz M; Kristensen SD; Hvas AM; Grove EL
    Curr Pharm Des; 2012; 18(33):5294-308. PubMed ID: 22724416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.